StockDuty ← Dashboard Nov 06, 2026 09:57 AM ET
SignalCorporate

Gyre Therapeutics GAAP EPS of -$0.04, revenue of $32.9M

Gyre Therapeutics reported GAAP EPS of -$0.04 and revenue of $32.9M.

Gyre Therapeutics reported GAAP EPS of -$0.04 and revenue of $32.9M.
Gyre Therapeutics reported GAAP EPS of -$0.04 and revenue of $32.9M. — impact context not separately stored; see What changed.
Sources